Literature DB >> 15844704

Elevated CA 19-9 caused by Hashimoto's thyroiditis: review of the benign causes of increased CA 19-9 level.

Javier L Parra1, Steven Kaplan, Jamie S Barkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15844704     DOI： 10.1007/s10620-005-2559-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  4 in total

1.  Increased serum CA 19-9 antibodies in Sjögren's syndrome.

Authors:  R Safadi; M Ligumsky; E Goldin; Y Ilan; Y S Haviv; S Nusair
Journal:  Postgrad Med J       Date:  1998-09       Impact factor: 2.401

Review 2.  The use of serologic tumor markers in gastrointestinal malignancies.

Authors:  M R Posner; R J Mayer
Journal:  Hematol Oncol Clin North Am       Date:  1994-06       Impact factor: 3.722

3.  2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Authors:  R C Bast; P Ravdin; D F Hayes; S Bates; H Fritsche; J M Jessup; N Kemeny; G Y Locker; R G Mennel; M R Somerfield
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

4.  CA 19-9 expression in subacute (de Quervain's) thyroiditis: an immunohistochemical study.

Authors:  K W Schmid; C Ofner; T Ramsauer; A Hittmair; M Tötsch; D Ladurner; W Böcker
Journal:  Mod Pathol       Date:  1992-05       Impact factor: 7.842
  4 in total
  10 in total

1.  CA 19-9 to rule out pancreatic or biliary cancer among patients with cholestasis: an unsuitable test?

Authors:  Salvatore Madonia; Emma Aragona; Simonetta Maisano; Luigi Montalbano; Mirko Olivo; Francesca Rossi; Gaetano Restivo; Mario Cottone
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

2.  [CA 19-9 in the differential diagnosis of pancreatic lesions].

Authors:  S Stintzing; C Herold; E G Hahn; F Boxberger
Journal:  Internist (Berl)       Date:  2008-02       Impact factor: 0.743

3.  Elevated serum CA 19-9 at screening tests: underlying conditions and role of abdominopelvic CT.

Authors:  Ji Yang Kim; Se Hyung Kim; Soo Young Kim
Journal:  Eur Radiol       Date:  2014-08-12       Impact factor: 5.315

4.  Risk factors for pancreatic adenocarcinoma and prospects for screening.

Authors:  G Anton Decker; Mashal J Batheja; Joseph M Collins; Alvin C Silva; Kristin L Mekeel; Adyr A Moss; Cuong C Nguyen; Douglas F Lake; Laurence J Miller
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-04

5.  Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion.

Authors:  Konstantinos Karatolios; Sabine Pankuweit; Bernhard Maisch
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

6.  Preoperative Alkaline Phosphatase-adjusted CA19-9 as a Superior Prognosticator for Extrahepatic Biliary Tract Cancer With Jaundice.

Authors:  Shinichi Ikuta; Tsukasa Aihara; Takayoshi Nakajima; Meidai Kasai; Naoki Yamanaka
Journal:  Cancer Diagn Progn       Date:  2022-09-03

7.  A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion.

Authors:  Piotr Hogendorf; Aleksander Skulimowski; Adam Durczyński; Anna Kumor; Grażyna Poznańska; Aleksandra Oleśna; Joanna Rut; Janusz Strzelczyk
Journal:  Dis Markers       Date:  2017-03-05       Impact factor: 3.434

8.  Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer.

Authors:  Cheng Peng; Jiale Wang; Wenzhe Gao; Lihua Huang; Yunfei Liu; Xia Li; Zhiqiang Li; Xiao Yu
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

9.  Correlation between serum carbohydrate antigen 19-9 levels and computed tomography severity score in patients with nontuberculous mycobacterial pulmonary disease.

Authors:  Kangjoon Kim; Seung Hyun Yong; Su Hwan Lee; Sang Hoon Lee; Ah Young Leem; Song Yee Kim; Kyungsoo Chung; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Hye-Jeong Lee; Young Ae Kang
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

10.  Factors associated with serum CA19-9 levels among healthy children: a cross-sectional study.

Authors:  Sayo Kawai; Nobuyuki Hamajima; Sueli M Oba-Shinjo; Lucy S Ito; Miyuki Uno; Suely K N Marie
Journal:  BMC Clin Pathol       Date:  2012-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.